Neogen (NASDAQ:NEOG) Stock Crosses Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• Technical: Neogen shares crossed above their 200-day moving average
• Analyst consensus: The stock has a consensus rating of Hold with a $10.67 average target, based on 2 Buys, 3 Holds and 1 Sell, while some firms (Piper Sandler, Guggenheim) have raised price objectives.
• Fundamentals: Latest quarterly results beat estimates (EPS $0.09 vs $0.04; revenue $211.2M vs $204.6M) but revenue was down 4.4% year‑over‑year and the company shows a negative net margin and a negative P/E, indicating ongoing profitability pressures.

Neogen Corporation (NASDAQ:NEOG - Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $8.35 and traded as high as $9.51. Neogen shares last traded at $9.34, with a volume of 3,466,127 shares changing hands.

Wall Street Analyst Weigh In

NEOG has been the topic of several analyst reports. Weiss Ratings restated a "sell (d-)" rating on shares of Neogen in a report on Friday, April 10th. Wall Street Zen lowered shares of Neogen from a "buy" rating to a "hold" rating in a report on Saturday, April 11th. Piper Sandler restated a "neutral" rating and issued a $10.00 price objective (up from $6.50) on shares of Neogen in a report on Monday, January 12th. William Blair restated a "market perform" rating on shares of Neogen in a report on Monday, March 2nd. Finally, Guggenheim restated a "buy" rating and issued a $12.00 price objective (up from $8.00) on shares of Neogen in a report on Friday, January 9th. Two analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Neogen currently has an average rating of "Hold" and a consensus target price of $10.67.

Neogen Price Performance

The company has a debt-to-equity ratio of 0.38, a current ratio of 3.92 and a quick ratio of 2.84. The stock has a market cap of $2.03 billion, a P/E ratio of -3.34, a P/E/G ratio of 4.30 and a beta of 1.97. The company's 50 day simple moving average is $9.77 and its 200 day simple moving average is $8.35.

Neogen (NASDAQ:NEOG - Get Free Report) last issued its earnings results on Thursday, April 9th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.04 by $0.05. Neogen had a negative net margin of 69.93% and a positive return on equity of 2.35%. The firm had revenue of $211.20 million during the quarter, compared to the consensus estimate of $204.62 million. The business's revenue was down 4.4% compared to the same quarter last year. As a group, equities analysts forecast that Neogen Corporation will post 0.22 earnings per share for the current year.

Institutional Investors Weigh In On Neogen

Several large investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Neogen by 1.6% in the third quarter. Vanguard Group Inc. now owns 23,963,223 shares of the company's stock valued at $136,830,000 after purchasing an additional 385,885 shares in the last quarter. ING Groep NV bought a new stake in shares of Neogen during the third quarter worth $80,288,000. T. Rowe Price Investment Management Inc. increased its position in shares of Neogen by 249.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company's stock worth $57,191,000 after acquiring an additional 5,838,570 shares in the last quarter. Mackenzie Financial Corp increased its position in shares of Neogen by 1.0% during the fourth quarter. Mackenzie Financial Corp now owns 7,898,439 shares of the company's stock worth $55,574,000 after acquiring an additional 79,010 shares in the last quarter. Finally, Cibc World Markets Corp bought a new stake in shares of Neogen during the fourth quarter worth $47,983,000. Institutional investors own 96.73% of the company's stock.

About Neogen

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen's product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.